Cargando…
PSMA PET-directed surgical metastasis-directed therapy in metachronous prostate cancer
We present the case of a patient who underwent an open radical prostatectomy with pelvic lymph node dissection (Gleason 4+3, pT3a pN1 R0) in March 2017. In November 2020, prostate-specific membrane antigen (PSMA)-radioguided salvage lymph node dissection was planned due to a single left para-rectal...
Autores principales: | Ambrosini, Francesca, Koehler, Daniel, Ghadban, Tarik, Jacobsen, Frank, Knipper, Sophie, von Amsberg, Gunhild, Steuber, Thomas, Maurer, Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Polish Urological Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10690390/ https://www.ncbi.nlm.nih.gov/pubmed/38045775 http://dx.doi.org/10.5173/ceju.2023.69 |
Ejemplares similares
-
Multimodal therapy in oligometastatic prostate cancer: A glimpse into the future?
por: Knipper, Sophie, et al.
Publicado: (2021) -
EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer
por: Falkenbach, Fabian, et al.
Publicado: (2023) -
Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support
por: Falkenbach, Fabian, et al.
Publicado: (2023) -
Management of Patients with Recurrent and Metachronous Oligometastatic Prostate Cancer in the Era of PSMA PET
por: Sabbagh, Ali, et al.
Publicado: (2022) -
Evaluation of [(68) Ga]Ga-PSMA-I&T PET/CT with additional late scans of the pelvis in prostate-specific antigen recurrence using the PROMISE criteria
por: Koehler, Daniel, et al.
Publicado: (2022)